Rantis P C, Vernava A M, Daniel G L, Longo W E
Department of Surgery, Saint Louis University School of Medicine, MO 63110-0250, USA.
Dis Colon Rectum. 1997 Mar;40(3):280-6. doi: 10.1007/BF02050416.
Chronic constipation can be a disabling condition that may require colectomy. Evaluation has been included as a way to select appropriate patients for colectomy and may also be extensive, unrevealing, and costly.
This study was undertaken to determine the cost and use of evaluation and outcome of patients with chronic constipation.
Patients with chronic constipation were reviewed for severity of symptoms, diagnostic studies performed, treatment, and outcome. The costs of the diagnostic studies were determined at our institution. Fifty-one patients were identified with chronic constipation; all were referred by other physicians. Mean age was 54 (range, 21-81) years; 59 percent were females. Average number of bowel movements per week was two (range, 0-4), and average duration of symptoms was five years (range, 1-20). Forty-three of 51 (84 percent) colonoscopies or barium enemas were normal. Thirteen of 51 (25 percent) colonic transit studies were abnormal. Twenty-six of 51 (51 percent) patients underwent defecography; 12 (46 percent) were abnormal. Thirty-seven of 51 (74 percent) underwent anal manometry; 5 (14 percent) were abnormal. One of 18 (6 percent) rectal biopsies demonstrated Hirschsprung's disease. Overall, 8 patients (16 percent) were diagnosed with outlet obstruction, 12 (24 percent) with colonic inertia, and 31 (61 percent) with constipation of unclear etiology. Overall mean cost of diagnosis was $2,752 (range, $1,150-$4,792). Fiber, cathartics, or biofeedback therapy was successful in 33 of 51 (65 percent) patients. Among the remaining 18 patients, 12 underwent surgery, of which 10 were successful. The remaining eight patients were constipated, despite treatment.
A cost of $140,369 was expended on extensive diagnostic tests, from which 12 of 51 (23 percent) patients benefited. Exhaustive diagnostic evaluation of constipation is costly, and its benefits are unclear.
慢性便秘可能是一种致残性疾病,可能需要进行结肠切除术。评估已被视为选择合适的结肠切除术患者的一种方法,而且评估可能范围广泛、无结果且成本高昂。
本研究旨在确定慢性便秘患者的评估成本、评估的使用情况及治疗结果。
对慢性便秘患者的症状严重程度、所进行的诊断性检查、治疗及结果进行了回顾。在我们机构确定了诊断性检查的成本。确定了51例慢性便秘患者;均由其他医生转诊。平均年龄为54岁(范围21 - 81岁);59%为女性。每周平均排便次数为2次(范围0 - 4次),症状平均持续时间为5年(范围1 - 20年)。51例患者中43例(84%)的结肠镜检查或钡剂灌肠结果正常。51例患者中13例(25%)的结肠传输试验异常。51例患者中26例(51%)接受了排粪造影;12例(46%)异常。51例患者中37例(74%)接受了肛门测压;5例(14%)异常。18例患者中有1例(6%)直肠活检显示患有先天性巨结肠病。总体而言,8例患者(16%)被诊断为出口梗阻,12例(24%)为结肠无力,31例(61%)为病因不明的便秘。诊断的总体平均成本为2752美元(范围1150 - 4792美元)。纤维、泻药或生物反馈疗法在51例患者中的33例(65%)取得成功。在其余18例患者中,12例接受了手术,其中10例成功。其余8例患者尽管接受了治疗仍便秘。
在广泛的诊断检查上花费了140369美元,51例患者中有12例(23%)从中受益。对便秘进行详尽的诊断评估成本高昂,其益处尚不清楚。